When does basiliximab’s patent expire in the Philippines?
I don’t have enough source information here to state a specific basiliximab patent expiry date in the Philippines. Patent expiry can vary by country because it depends on the particular Philippine filing(s), whether there were extensions or supplementary protections, and whether any patent terms were adjusted due to regulatory or other legal events.
Which patents usually control basiliximab’s market exclusivity (and why that matters)?
Even for the same medicine, multiple patents can be relevant, such as patents on the molecule, specific formulations, manufacturing processes, or related inventions. In the Philippines, the patent that blocks competition (and when generic or biosimilar entry becomes possible) is the one(s) that still have enforceable claims, not necessarily the earliest filing date.
How to find the actual expiry date for basiliximab in the Philippines (practical steps)
To get the correct expiry date, you typically need to:
1) Identify the specific Philippine patents assigned to or covering basiliximab (and any later division/continuation entries).
2) Check each patent’s grant date and term as recorded by the Philippine intellectual property office records.
3) Confirm whether any later events affect enforceability (for example, related registrations or legal actions that stop or delay entry).
If you share the brand name you mean (for example, Simulect) and the patent holder/company listed on Philippine records, I can help you interpret the relevant patent records and translate them into an expiry window.
Does Philippine “patent expiry” equal biosimilar entry date?
Not always. Biosimilar or generic availability can depend on more than patent term, including:
- Whether the product is approved/registered by the Philippine regulator.
- Patent disputes, court orders, or settlements that delay launch.
- Exclusivity periods and how regulators treat patent-referenced originator products.
If you want, tell me what to look up
To pinpoint the expiry date, reply with one of the following:
- the Philippine patent number(s) you found, or
- the patent holder/assignee name and the brand you mean (e.g., Simulect).
Then I can help narrow down the exact expiry (and which patent(s) likely matter for market entry) using those identifiers.